Toggle light / dark theme

After just over 10 and a half days in space, Peregrine Mission One, which was hosted by the private space company, Astrobotic Technology, burned up in the Earth’s atmosphere over the South Pacific Ocean on January 18, 2024, at approximately 4:04 pm EST (1:04 pm EST). This concluded what is being deemed as a mostly successful mission for the first commercial mission for NASA’s Commercial Lunar Payload Services (CLPS) program, although the spacecraft was unable to land on the lunar surface due to a fuel leak that occurred about seven hours after launch on January 8, 2024. Despite this, Peregrine was able to test several of its onboard instruments during the short mission, which will provide valuable data for future missions to the Moon, specifically for NASA’s Artemis program.

Had Peregrine landed on the Moon, it would have marked the first time a US-built spacecraft would have landed on the lunar surface since NASA’s Apollo 17 in 1972. Despite this, four of the five instruments on Peregrine successfully collected data during the 10-day mission: Linear Energy Transfer Spectrometer (LETS), Near-Infrared Volatile Spectrometer System (NIRVSS), Neutron Spectrometer System (NSS), Peregrine Ion-Trap Mass Spectrometer (PITMS), with the fifth instrument, NASA’s Laser Retroreflector Array (LRA), designed to only be used on the lunar surface.

“Astrobotic’s Peregrine mission provided an invaluable opportunity to test our science and instruments in space, optimizing our process for collecting data and providing a benchmark for future missions,” said Dr. Nicola Fox, who is the associate administrator for NASA’s Science Mission Directorate at NASA Headquarters. “The data collected in flight sets the stage for understanding how some of our instruments may behave in the harsh environment of space when some of the duplicates fly on future CLPS flights.”

LONDON (AP) — U.K. health officials on Monday urged millions of parents to book their children for missed measles, mumps and rubella shots during a sharp increase in the number of measles cases and the lowest vaccination rates in a decade.

The National Health Service is launching a publicity campaign after figures showed there were about 250 confirmed measles cases in parts of England last year. Most cases were in children under 10 years old.

The combined measles, mumps and rubella, or MMR, vaccine is offered in the U.K. in two doses to all children, first at 12 months and then again at 3 years. Vaccination rates have dropped to about 85% nationally, and far lower in parts of London, according to U.K. Health Security Agency chief executive Jenny Harries.

Organic mixed ionic–electronic conductors (OMIECs) are a highly sought-after class of materials for non-conventional applications, such as bioelectronics, neuromorphic computing, and bio-fuel cells, due to their two-in-one electronic and ionic conduction properties.

To ensure a much wider acceptance of these fascinating materials, there is a need to diversify their properties and develop techniques that allow application-specific tailoring of the features of OMIEC-based devices.

A crucial aspect of this process is to develop strategies for evaluating the various properties of these materials. However, despite the increasing popularity of OMIECs, there is a severe lack of research on the molecular orientation-dependent transient behaviors of such conductors.

In a new article published in the journal Nature Reviews Neuroscience, researchers make the case that the human brain also develops a cellular template soon after birth which defines who we are and how we perceive the world.


For centuries, a prevailing theory in philosophy has asserted that at birth the human mind is a blank slate. More recently, the same notion has also held sway in the field of neurobiology, where it is commonly held that neural connections are slowly created from scratch with the accumulation of sensory information and experience.

Eventually, the theory goes, this allows us to create memories in space and time and to then learn from those experiences.

But after spending more than a decade studying activity in the hippocampus, the area of brain which forms memory, Yale’s George Dragoi began to have his doubts.

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses advances in Alzheimer’s therapy.

In 1999, I defined regenerative medicine as the collection of interventions that restore normal function to tissues and organs damaged by disease, injured by trauma, or worn by time. I include a full spectrum of chemical, gene, and protein-based medicines, cell-based therapies, and biomechanical interventions that achieve that goal.

An emerging combination of focused ultrasound therapy with a recently approved medication could be our best treatment for Alzheimer’s disease to date. In the New England Journal of Medicine, Dr. Ali Rezai and colleagues from West Virginia University describe an approach to reduce cerebral amyloid-beta load, a biomarker for neurodegeneration, in patients with Alzheimer’s. While in its preliminary stages, the combination treatment can potentially help thousands, if not millions, suffering from the disease in the near future.

Twitter files author Michael Shellenberger weighs in on recent leaked NIH emails. #Fauci #covidorigins.

About Rising:
Rising is a weekday morning show with bipartisan hosts that breaks the mold of morning TV by taking viewers inside the halls of Washington power like never before. The show leans into the day’s political cycle with cutting edge analysis from DC insiders who can predict what is going to happen. It also sets the day’s political agenda by breaking exclusive news with a team of scoop-driven reporters and demanding answers during interviews with the country’s most important political newsmakers.

Follow Rising on social media:

Website: Hill. TV